Manufacturer: Deus Medical, Europe
Pharmaceutical name: Pentadecapeptide
Pack: 1 vial (5 mg)
BPC-157 (Pentadecapeptide) is an innovative and stable compound comprised of 15 amino acids, which was partially derived from human gastric juice. It has been employed in the management of ulcers and various other injuries. It is produced as a BPC-157 (Pentadecapeptide) injection containing 5mg of Pentadecapeptide per vial along with excipients.
BPC-157 (Pentadecapeptide) Mechanism of Action:
BPC-157 (Body Protection Compound - 157) has demonstrated protective effects on cells. The unique combination of 15 amino acids in this compound is not naturally occurring but is a derivative of human gastric juice. The action of Pentadecapeptide is primarily linked to angiogenesis (the formation of blood vessels), which contributes to the establishment of an extensive vascular network that supports tissue regeneration. Research has shown that BPC-157 can diminish the extent of ulceration and aid in the healing or regeneration of ulcers. Another potential mechanism involves the inhibition of the growth-inhibiting factor 4-hydroxynonenal, which facilitates greater growth and regeneration. Additionally, BPC-157 (Pentadecapeptide) offers protection to the stomach lining against harmful substances. Its regenerative characteristics also suggest it may stimulate the growth of tendon cells and may play a role in the regeneration of neuronal cells.
BPC-157 (Pentadecapeptide) Dosage:
The recommended dosage is 200 - 400mcg daily, administered via intramuscular injections.
BPC-157 (Pentadecapeptide) Side Effects:
Potential side effects include pain at the injection site, inflammation, fatigue, and dizziness.
BPC-157 (Pentadecapeptide) Interactions:
Possible interactions with nitric oxide and dopamine.